Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors
Zijie Cai(Sun Yat-sen University), Qiang Liu(Sun Yat-sen University), Yandan Yao(Sun Yat-sen University), Lok Lam Wong(Sun Yat-sen University), Shunying Li(Sun Yat-sen University), Chang Gong(Sun Yat-sen University), Herui Yao(Sun Yat-sen University), Yudong Li(Zhengzhou University), Qi Wang(Hebei Medical University), Jun Zhang(OSF HealthCare), Yujie Liu(Sun Yat-sen University), Yang Wang(Shandong Provincial Hospital), Liang Jin(Kunming Medical University), Jingru Wang(Sun Yat-sen University), Hongna Lai(Sun Yat-sen University), Qianfeng Shi(Sun Yat-sen University), Mengdi Zhu(Sun Yat-sen University)
Cited by 108
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
|The Lancet Public Health|2020|1.8k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells
|Molecular Cancer|2011|700
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer’s disease
|Journal of Structural Biology|2005|585